Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

NGL Fine-Chem Limited

NGLFINE.NSNSE
Healthcare
Drug Manufacturers - General
2304.40
61.90(2.76%)
Indian Market opens in 3h 42m

NGL Fine-Chem Limited (NGLFINE.NS) Stock Overview

Explore NGL Fine-Chem Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.2B
P/E Ratio40.56
EPS (TTM)$57.17
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$2324.68
3 Months$661.13
1 Year Target$1579.55

NGLFINE.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NGL Fine-Chem Limited (NGLFINE.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1579.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 40.56 and a market capitalization of 14.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.76%
5-Day Change
-1.86%
1-Month Change
47.13%
3-Month Change
73.48%
6-Month Change
61.47%
Year-to-Date (YTD) Change
65.001%
1-Year Change
110.35%
3-Year Change
80.77%
5-Year Change
23.30%
All-Time (Max) Change
23.30%

Contact Information

91 22 4084 2222
301, E Square, Mumbai, NaN, 400057

Company Facts

6,820 Employees
IPO DateJul 8, 2022
CountryIN
Actively Trading

Frequently Asked Questions